NeoGenomics (NEO)
(Delayed Data from NSDQ)
$13.68 USD
-0.17 (-1.23%)
Updated Apr 17, 2024 04:00 PM ET
After-Market: $13.70 +0.02 (0.15%) 7:58 PM ET
2-Buy of 5 2
C Value A Growth C Momentum B VGM
Brokerage Reports
0 items in cart
NeoGenomics, Inc. [NEO]
Reports for Purchase
Showing records 1 - 20 ( 132 total )
Company: NeoGenomics, Inc.
Industry: Medical - Biomedical and Genetics
Optimized Entry and Exit Levels for NEO 112223
Provider: Stock Traders Daily
Analyst: Research Department
Company: NeoGenomics, Inc.
Industry: Medical - Biomedical and Genetics
Company: NeoGenomics, Inc.
Industry: Medical - Biomedical and Genetics
Company: NeoGenomics, Inc.
Industry: Medical - Biomedical and Genetics
Dropping Coverage due to reallocate our research resources.
Provider: Roth Capital Partners, Inc.
Company: NeoGenomics, Inc.
Industry: Medical - Biomedical and Genetics
We are dropping coverage of the following stocks
Provider: Roth Capital Partners, Inc.
Company: NeoGenomics, Inc.
Industry: Medical - Biomedical and Genetics
Company: NeoGenomics, Inc.
Industry: Medical - Biomedical and Genetics
Company: NeoGenomics, Inc.
Industry: Medical - Biomedical and Genetics
2018 Top Stock Picks
Provider: G.RESEARCH, LLC
Company: NeoGenomics, Inc.
Industry: Medical - Biomedical and Genetics
Company: NeoGenomics, Inc.
Industry: Medical - Biomedical and Genetics
Company: NeoGenomics, Inc.
Industry: Medical - Biomedical and Genetics
Healthcare - Coverage Update - Healthcare Sector
Provider: Roth Capital Partners, Inc.
Company: NeoGenomics, Inc.
Industry: Medical - Biomedical and Genetics
Transferring Coverage due to the departure of the covering analyst
Provider: Roth Capital Partners, Inc.
Analyst: HENRY S
Company: NeoGenomics, Inc.
Industry: Medical - Biomedical and Genetics
We are placing shares of NEO Under Review, and transferring coverage to Scott Henry, CFA due to the departure of the covering analyst.
Provider: Roth Capital Partners, Inc.
Company: NeoGenomics, Inc.
Industry: Medical - Biomedical and Genetics
Company: NeoGenomics, Inc.
Industry: Medical - Biomedical and Genetics
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: NeoGenomics, Inc.
Industry: Medical - Biomedical and Genetics
Solid 2Q on Strong Volume Growth, Pharma Acceleration
Provider: Roth Capital Partners, Inc.
Analyst: LEWIS C
Company: NeoGenomics, Inc.
Industry: Medical - Biomedical and Genetics
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: NeoGenomics, Inc.
Industry: Medical - Biomedical and Genetics
Analyst Day Takeaways - Integration Now Complete, Time to Realize Benefits
Provider: Roth Capital Partners, Inc.
Analyst: LEWIS C
Company: NeoGenomics, Inc.
Industry: Medical - Biomedical and Genetics
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: NeoGenomics, Inc.
Industry: Medical - Biomedical and Genetics
Despite Disruptions, Integration Now\ Complete - Table Set for Synergies
Provider: Roth Capital Partners, Inc.
Analyst: LEWIS C